Stockreport

Recursion (RXRX) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF The Zacks Consensus Estimate for first-quarter revenues is pinned at $13.4 million, suggesting a 10% increase from the year-ago quarter's reported figure. Let us see h [Read more]